Abstract
Tumor growth control is described especially as it pertains to tumor heterogeneity. Four facets heterogeneity are reviewed; statistical or distributional heterogeneity, epigenetic or environmental heterogeneity, emergence of intrinsic or clonal heterogeneity, and the development of clonal subpopulations in a heterogeneous micro-environment. A model of tumor growth and its control is developed. Growth control is defined for a heterogeneous tumor composed of a cycling, proliferative compartment and a non-cycling, quiescent one. The paradigm for this form of heterogeneity is hypoxia in a solid tumor. It is used to establish a linkage between the carrying capacity of a tumor-bearing host for its tumor burden. The model is then applied to three disparate tumor growth phenomena. Each study is accompanied by an exploration of what we know (the experimental and clinical literature describing the phenomenon), what we think we know (a summary of the underlying growth processes we surmise accounts for the phenomenon), what we wish we know (areas which are still unexplored in the laboratory or clinic), and a description of the experiment and its analysis (a means of gathering and analyzing the missing information to complete a picture of the phenomenon in question).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adam J.A. and Maggelakis S.A., Diffusion regulated growth characteristics of the spherical prevascular carcinoma, Bull. Math. Biol., 52 (1990), 549–582.
Asaga T., Suzuki K., Umeda M., Sugimasa Y., Takemiya S., and Okamoto T., The enhancement of tumor growth after partial hep-atectomy and the effect of sera obtained from hepatectomized rats on tumor cell growth, Japanese J. Surg., 21 (1991), 669–675.
Brattain M.G., Fine W.D., Khaled F.M., Thompson J., and Brattain D.E., Heterogeneity of malignant cells from a human colonic carcinoma, Cancer Res., 41 (1981), 1751–1756.
Bronk B.V., Dienes G.J., and Paskin A., The stochastic theory of cell proliferation, Biophys. J., 8 (1968), 1353–1398.
Ciampi, Kates A.L., Buick R., Kruikov Y., and Till J.E., Multi-type Galton-Watson process as a model for proliferating human tumour cell populations derived from stem cells: Estimation of the stem cell self-renewal probabilities in human ovarian carcinomas, Cell Tissue Kinet., 19 (1986), 129–140.
Coldman A.J. and Goldie J.H., A model for the resistance of tumor cells to cancer chemotherapeutic agents, Math. Biosci., 65 (1983), 291–307.
Coldman A.J., Goldie J.H., and Ng V., The effects of cellular differentiation on the development of permanent drug resistance, Math. Biosci., 74 (1985), 177–198.
Day R.S., A branching process model for heterogeneous cell populations, Math. Biosci., 78 (1986), 73–90.
Durrant L.G., Watson S.A., Hall A., and Morris D.L., Co-stimulation of gastrointestinal tumor cell growth by gastrin, transforming growth factor-α and insulin-like growth factor-1, Br. J. Cancer, 63 (1991), 67–70.
Dye E.S., Role of concomitant antitumor immunity in restraining tumor metastases, in Mechanisms of Host Resistance to Infectious Agents, Tumors, and Allografts, Steinman R.M. and North R.J. eds., Rockefeeler University Press (1986), 197–411.
Ehrlich P., Experimentelle Coarcinomatuien an Mausen, Arb. Koniglichen Inst. Exp. Ther. Frankfurt, 1 (1906), 65–103.
Fausto N., Growth factors in liver development, regeneration, and carcinogenesis, Progress in Growth Factor Research, 3 (1991), 219–234.
Fidler I.J., Orthotopic implantation of human colon carcinoma into nude mice provides a valuable model for the biology and therapy of metastasis, Cancer and Metastat. Rev., 10 (1991), 229–243.
Fisher B. and Fisher E.R., Experimental studies of factors influencing hepatic metastases I. The effect of the number of tumor cells injected and the time of growth, Cancer, 12 (1959), 926–928.
Fisher B. and Fisher E.R., Experimental studies of factors influencing hepatic metastases II. Effect of partial hepatectomy, Cancer, 11 (1959), 929–932.
Fisher B. and Fisher E.R., Experimental studies of factors influencing hepatic metastases III. Effect of surgical trauma with special reference to liver injury, Ann. Surg., 150 (1959), 731–744.
Fujiwara K., Nagoshi S., Ohno A., Hirata K., Ohta Y., Mochida S., Tomiya T., Higashio K., and Kurokawa K., Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partial hepatectomized rats, Hepatology, 18 (1993), 1443–1449.
Gahary A., Minuk G.Y., Lao J., Gauthier T., and Murphy L.J., Effects of partial hepatectomy on hepatic insulin-like growth factor binding protein-1 expression, Hepatology, 15 (1992), 1125–1131.
Gatenby R.A., Population ecology issues in tumor growth, Cancer Res., 51 (1991), 2542–2547.
German J., Chromosomal Mutation and Neoplasia, Alan R. Liss (1983).
Goldie J.H. and Coldman A.J., A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate, Cancer Treat. Rep., 63 (1979), 1727–1733
Goldie J.H. and Coldman A.J., The genetic origin of drug resistance in neoplasms: Implications for systemic therapy, Cancer Treat. Rep., 67 (1984), 923–931.
Goldie J.H., Coldman A.J., and Gudauskas G.A., Rationale for the use of alternating non-cross-resistant chemotherapy, Cancer Treat. Rep., 66 (1982), 439–449.
Goel N.S., Maitra S.C., and Montroll E.W., On the Volterra and other nonlinear models of interacting populations, Rev. Modern Physics, 43 (1971), 231–276.
Gorelik E., Concomitant tumor immunity and resistance to a second tumor challenge, Adv. Cancer Res., 39 (1983), 71–120.
Gyllenberg M. and Webb G.F., Quiescence as an explanation of Gompertzian tumor growth, Vanderbilt University Technical Report MAT-A264 (1989).
Gyllenberg M. and Webb G.F., A nonlinear structured population model of tumor growth with quiescence, J. Math. Biol., 28 (1990), 671–694.
Gyori I., Michelson S., and Leith J.T., Time-dependent subpop-ulation induction in heterogeneous tumors, Bull. Math. Biol., 50 (1988), 681–696.
Harris T.E., In The Kinetics of Cell Proliferation, Stohlman F. ed., Grune and Stratton (1959).
Heppner G.H., Tumor heterogeneity, Cancer Res., 44 (1984), 2259–2265.
Heppner G.H., Miller B.E., and Miller F.R., Tumor subpopulation interactions in neoplasms, Biochim. Biophys. Acta, 695 (1983), 215–226.
Jansson B. and Revesz L., Analysis of the growth of tumor cell populations, Math. Biosci., 19 (1975), 131–154.
Kan M., Huan J., Mansson P., Yamsumitsu H., Carr B., and McK-eehan W., Heparin-binding growth factor type II (acidic fibroblast growth factor): A potential biphasic autocrine and paracrine regulator of hepatocyte regeneration, Proc. Natl. Acad. Sci., 86 (1989), 7432–7436.
Kendal W.S., Gompertzian growth as a consequence of tumor heterogeneity, Math. Biosci., 73 (1985), 103–107.
Kuzcek T. and Chan T.C.K., Mathematical modeling for tumor resistance, JNCI, 80 (1988), 146–147.
Leith J.T., Harrigan P., Padfield G., and Michelson S., Modification of growth rates and hypoxic fractions of xenografted A431 tumors by sialoadenectomy or exogenously supplied epidermal growth factor, Cancer Res., 51 (1991), 4111–4113.
Leith J.T., Padfield G., and Michelson S., Effects of partial hep-atectomy on the growth characteristics and hypoxic fractions of xenografted DLD-2 human colon cancers, Rad. Res., 132 (1992), 263–268.
Leith J.T., Papa G., Quaranto L., and Michelson S., Modification of the volumetric growth responses and steady state hypoxic fractions of xenografted DLD-2 human colon carcinomas by administration of basic fibroblast growth factor or suramin, Br. J. Cancer, 66 (1992), 345–348.
Leith J.T. and Michelson S., Tumor radiocurability: Relationship to intrinsic tumor heterogeneity and the tumor bed effect, Inv. and Metast., 10 (1990), 329–351.
Leith J.T., Michelson S., Faulkner L.E., and Bliven S., Growth properties of artificial heterogeneous human colon tumors, Cancer Res., 47 (1987), 1045–1051.
Leith J.T., Faulkner L.E., Bliven S.F., and Michelson S., Tumor bed expression in xenografted artificial heterogeneous colon tumors, Int. J. Radiat. Oncol. Biol. Phys., 15 (1988), 151–158.
Leith J.T., Faulkner L.E., Bliven S.F., and Michelson S., Compositional stability of artificial heterogeneous tumors in vivo: Use of Mitomycin C as a cytotoxic probe, Cancer Res., 48 (1988), 2669–2673.
Loizidou M.C., Lawerence R.J., Holt S., Carty N.J., Cooper A.J., Alexander P., and Taylor I., Facilitation by partial hepatectomy of tumor growth within the rat liver following intraportal injection of syngeneic tumor cells, Clin, and Exp. Metastasis, 9 (1991), 335–349.
Marusic M., Bajzer Z., Freyer J.P., and Vuk-Pavlovic S., Analysis of growth of multicellular tumour spheroids by mathematical models, Cell Prolif., 27 (1994), 73–94.
Marusic M. and Vuk-Pavlovic S., Prediction power of mathematical models for tumor growth, J. Biol. Sys., 1 (1993), 69–78.
Matsumoto K. and Nakamura T., Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological factors, Crit. Revs, in Oncogenesis, 3 (1992), 27–54.
Mead J.E. and Fausto N., Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism, Proc. Natl. Acad. Sci., 86 (1989), 1558–1562.
Michelson S., Miller B.E., Glicksman A.S., and Leith J.T., Tumor microecology and competitive interactions, J. Theor. Biol., 128 (1987), 233–246.
Michelson S. and Leith J.T., Autocrine and paracrine growth factors in tumor growth, Bull. Math. Biol., 53 (1991), 639–656.
Michelson S. and Leith J.T., The autocrine-paracrine-endocrine triad of tumor growth control, in Proceedings of Third International Conference on Communications and Control, Victoria, B.C., Oct. 16-18 1991, Mohler R.H. and Wells W. eds., Vol. 2 (1992), 481–490.
Michelson S. and Leith J.T., Growth factors and growth control of heterogeneous cell populations, Bull. Math. Biol., 55 (1992), 993–1011.
Michelson S. and Leith J.T., Dormancy, regression, and recurrence: Towards a unifying theory of tumor growth control, J. Theor. Biol., 169 (1994), 327–338.
Michelson S. and Leith J.T., Interlocking triads of growth control in tumors, Bull. Math. Biol., 57 (1995), 345–366.
Michelson S., Tran H., Ito K., and Leith J.T., Stochastic models for subpopulation emergence in heterogeneous tumors, Bull. Math. Biol., 51 (1989), 731–747.
Michelson S., Comparison of stochastic models for tumor escape, in Immunology and Epidemiology, Hoffman G.W. and Hraba T. eds., Lecture Notes in Biomathematics, Vol. 65, Springer-Verlag (1986).
Michelson S., Immune surveillance: Towards a tumor specific model, in Theoretical Immunology, Part II, Perelson A. ed., Ad-dison-Wesley (1988), 37–56.
Michelson S., A system for Monte Carlo simulation of heterogeneous tumor cell populations, in Mathematical Models in Medicine: Diseases and Epidemics, Adv. Math. and Computers in Med., 20 (1990), 139–148.
Michelson S. and Leith J.T., Environmental stress induced by the tumor bed effect leads to subpopulation exclusion within heterogeneous neoplasms: Modeling studies, Radiation Res., 115 (1988), 533–542.
Michelson S. and Leith J.T., Effects of differential cell kill on the dynamic composition of heterogeneous tumors, in Mathematical Models in Medicine: Diseases and Epidemics, Adv. Math, and Computers in Med., 20 (1990), 149–160.
Michelson S. and Leith J.T., A theoretical explanation of “Concomitant Resistance”, Bull. Math. Biol., 57 (1995), 733–747.
Mohn K.L., Melby A.E., Tewari D.S., Laz T.M., and Taub R., The gene encoding rat insulin-like growth factor binding protein-1 is rapidly and highly increased in regenerating liver, Molec. Cell Biol, 11 (1991). 1393–1401.
Namieno T., Takeichi N., Hata Y., Uchinao J., and Kobayashi H., Kinetic changes of liver regeneration and hepatocellular carcinoma cells after partial hepatectomy in rats, Gastroenterologia Japonica, 26 (1991), 29–36.
Nowell P.C., Mechanisms of tumor progression, Cancer Res., 44 (1986), 3801–3805.
O’Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Chao Y., Sage E.H., and Folkman J., Angio-statin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis Lung carcinoma, Cell, 79 (1994), 315–328.
Panis Y., Ribeiro J., Chretien Y., and Nordlinger B., Dormant liver metastases: An experimental study, Br. J. Surg., 79 (1992), 221–223.
Paschkis K.E., Cantarow A., Stasney J., and Hobbs J.H., Tumor growth in partially hepatectomized rats, Cancer Res., 15 (1955), 579–582.
Poste G., Doll J., and Fidler I.J., Interactions among clonal subpop-ulations affect stability of the metastatic phenotype in polyclonal populations of the B16 melanoma cell, PNAS, 78 (1981), 6226–6230.
Poste G., Greig R., Tzeng J., Koestler T., and Corwin S., Interactions between tumor cell subpopulations in malignant tumors, in Cancer and Metastases: Biological and Therapeutic Aspects, Nicolson G.L. and Milas L. eds., Raven Press (1984).
Prehn R.T., The inhibition of tumor growth by tumor mass, Cancer Res., 51 (1991),.
Prehn R.T., Two competing influences that may explain concomitant tumor resistance, Cancer Res., 53 (1993), 3266–3269.
Roberts A.B., Anzano M.A., Wakefield L.M., Roche N.S., Stern D.F., and Sporn M.B., Type beta transforming growth factor: A bifunctional regulator of cellular growth, PNAS, 82 (1985), 119–123.
Rockwell S., Effect of host age on the transplantation, growth, and radiation response of EMT6 tumors, Cancer Res., 41 (1981), 527.
Rubin J.S., Chan A.M., Bottaro D.P., Burgess W.H., Taylor W.G., Cech A.C., Hirschfeld D.W., Wong J., Miki T., Finch P.W., and Aaronson S.A., A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor, Proc. Natl. Acad. Sci., 88 (1991), 415–419.
Rubinow S.I., A maturity-time representation for cell populations, Biophysical J., 8 (1968), 1055–1073.
Rubinow S.I., A simple model of a steady state differentiating cell system, J. Cell Biol., 43 (1969), 32–39.
Ruggerio R.A., Buatuoabad O.D., Bonfil R.D., Meiss R.P., and Pasqualini C.D., “Concomitant immunity” in murine tumors of non-detectable immunogenicity, Br. J. Cancer, 51 (1985), 37–48.
Ruggerio R.A., Buatuoabad O.D., Cramer P., Bonfil R.D., and Pasqualini C.D., Correlation between seric antitumor activity and concomitant resistance in mice bearing nonimmunogenic tumors, Cancer Res., 50 (1990), 7159–7165.
Schimke R.T., Gene amplification, drug resistance, and cancer, Cancer Res., 44 (1984), 1735–1742.
Schimke R.T., Gene amplification in cultured cells, J. Biol. Chem., 44 (1988), 1735–1742.
Stoll B.A., Spontaneous regression of cancer: New insights, Bio-therapy, 4 (1992), 23–30.
Truco E., Mathematical models for cellular systems: The Von Foer-ster equation. Part I, Bull. of Math. Biophys., 27 (1965), 283–303.
Truco E., Mathematical models for cellular systems: The Von Foer-ster equation. Part II, Bull, of Math. Biophys., 27 (1965), 449–471.
Tucker S.L., Cell population models with continuous structure variables, in Cancer Modeling, Brown B.W. and Thompson J.R. eds., Marcel Decker (1987).
Von Foerster H., Some remarks on changing populations, in The Kinetics of Cellular Proliferation, Stohlman F. ed., Grune and Stratton (1959).
Webb G.F., A nonlinear cell population model of periodic chemotherapy treatment, WSSIAA, 1 (1992), 569–583.
Wette R., Katz I.N., and Rodin E.Y., Stochastic processes for solid tumor kinetics I. Surface regulated growth, Math. Biosci., 19 (1974), 231–255.
Wette R., Katz I.N., and Rodin E.Y., Stochastic processes for solid tumor kinetics II. Diffusion regulated growth, Math. Biosci., 19 (1974), 311–338.
Wijsman J.H., Cornelisse C.J., Keijzer R., van de Velde C.J.H., and van Dierendonck J.H., A prolactin-dependent, metastasizing rat mammary carcinoma as a model for endocrine related tumour dormancy, Br. J. Cancer, 64 (1991), 463–468.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Michelson, S., Leith, J.T. (1997). Tumor Heterogeneity and Growth Control. In: Adam, J.A., Bellomo, N. (eds) A Survey of Models for Tumor-Immune System Dynamics. Modeling and Simulation in Science, Engineering, & Technology. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-0-8176-8119-7_7
Download citation
DOI: https://doi.org/10.1007/978-0-8176-8119-7_7
Publisher Name: Birkhäuser, Boston, MA
Print ISBN: 978-1-4612-6408-8
Online ISBN: 978-0-8176-8119-7
eBook Packages: Springer Book Archive